Efficacy of an intracervical prostaglandin E2 preparation, Cerviprost, on cervical ripening before first trimester abortion in nulliparous patients.
Irvine
L M
LM
Shaw
R W
RW
D000028:Abortion, Induced; D000758:Anesthesia; D001695:Biology; D001723:Birth Rate; D002584:Cervix Uteri; D003710:Demography; D004703:Endocrine System; D005193:Family Planning Services; D005298:Fertility; D005835:Genitalia; D005836:Genitalia, Female; D007747:Labor Stage, First; D010298:Parity; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D011453:Prostaglandins; D012098:Reproduction; D012106:Research; D012107:Research Design; D013812:Therapeutics; D014566:Urogenital System; D014599:Uterus
D011453:Prostaglandins
Abortion, Drug Induced; Abortion, Induced; Anesthesia; Biology; Cervical Dilatation; Cervical Effects; Cervix; Control Groups; Demographic Factors; Endocrine System; Family Planning; Fertility; Fertility Control, Postconception; Fertility Measurements; Genitalia; Genitalia, Female; Nulliparity; Parity; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy, First Trimester; Prospective Studies; Prostaglandins--administraction and dosage; Prostaglandins--side effects; Reproduction; Research Methodology; Studies; Treatment; Urogenital System; Uterus